Licensed Practical Nurse in Blaine, MN Accepting Medicare

6 Licensed Practical Nurse nurses found. Showing 1 - 6

Enid Lwiindi Mumba, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1013 111th Ave Ne, Blaine, MN 55434 Phone: 763-572-3707    Fax: 763-862-7438

Thea Marie Nelson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1013 111th Ave Ne, Blaine, MN 55434 Phone: 763-245-3643    Fax: 763-862-7438

Alice Tembo, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1013 111th Ave Ne, Blaine, MN 55434 Phone: 763-245-3643    Fax: 763-862-7438

Melissa Hoyt, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10141 University Ave Ne Ste 300, Blaine, MN 55434 Phone: 888-525-7742

Helena Musu Kidau, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 9500 Able St Ne, Blaine, MN 55434 Phone: 920-940-4219

Devlin Stitt, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 12259 Jefferson St Ne, Blaine, MN 55434 Phone: 612-870-3787    Fax: 612-870-3798

News Archive

KalVista begins Phase I trial of novel plasma kallikrein inhibitor for treatment of DME

KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces that it has begun a Phase I, First in Human, trial of its novel plasma kallikrein inhibitor, KVD001, for the treatment of DME.

Infections impact blood vessel repair within the meninges following TBI or other cerebrovascular injuries

Viral Infection Slows Blood Vessel Repair After TBI: Seven days after mTBI, the blood vessels (stained in red) in the tissues around the brain are not completely repaired. A marker for intact vessels was used (labeled in green) to distinguish fully functional blood vessels (yellow) from ones that are still damaged (red).McGavern Lab, NINDS

FDA accepts ACT Biotech's ACTB1003 IND

ACT Biotech Inc., a privately held biotechnology company developing a portfolio of oral kinase inhibitors as anti-cancer drugs, today announced the acceptance of the Investigational New Drug (IND) application for ACTB1003 by the US Food and Drug Administration (FDA). The company has now assembled a complete preclinical package, including manufacturing and toxicology studies, allowing ACTB1003 to enter a clinical trial.

Elsevier announces the winners of Asian Young Women Researcher Awards

Elsevier announced today the winners of the Asian Young Women Researcher Awards, a joint development between its flagship product Scopus(R), the world's largest abstract and citation database of peer-reviewed literature and the Third World Organisation for Women in Science (TWOWS) and TWAS, the academy of sciences for the developing world.

Congressman Chaka Fattah shoots back at "baloney" from Republicans

Congressman Chaka Fattah (D-PA) shot back today at what he called "baloney" coming from Washington Republicans: "Every step along the way these nattering nabobs of negativity have said we couldn't get it done. They said we would never move a bill out of Energy and Commerce. They said the Senate Finance Committee would never report a bill. They said the House vote would be strictly party lines and that the Senate would never let it out. Well, here we are at the finish line, and they're at it again.

Read more Medical News

› Verified 7 days ago